HHS and FDA announce reforms to accelerate clinical trials and restore US research leadership
By
Ruxandra Teslo
Summary
The Department of Health and Human Services (HHS), along with Acting FDA Commissioner Kyle Diamantas and NIH Director Jay Bhattacharya, announced new reforms aimed at restoring American leadership in clinical research. The plans focus on removing barriers to clinical trials, expediting Phase I timelines by six to twelve months, and encouraging companies to conduct studies in the US through an expedited investigational new drug process.
Source
Twitter / XHHS and FDA announce reforms to accelerate clinical trials and restore US research leadershipwritingruxandrabio.comKey quotes
· 3 pulledActing FDA Commissioner Kyle Diamantas and NIH Director Jay Bhattacharya outlined a series of reforms designed to hasten Phase I trials and encourage companies to conduct studies in the US.
The FDA's efforts are intended to reduce Phase I timelines by six to twelve months.
Today, the Department of Health and Human Services (HHS) announced new plans aimed at restoring American leadership in clinical research by removing unnecessary barriers to clinical trials.
You might also wanna read
U.S. Retreat from Global Health Leadership Exposes Pandemic Preparedness Gaps
The article, written by Dhruv Khullar, critiques the Trump Administration's retreat from global health leadership, as exemplified by NIH Dir
newyorker.com·1d ago
Health equity researchers warn White House grant proposal could threaten federal funding for disparities studies
A White House proposal to overhaul federal grant-making processes contains provisions that health disparities researchers say could disquali
statnews.com·14h agoHealth equity researchers warn White House grant proposal could threaten federal funding for disparities studies
A White House proposal to overhaul federal grant-making processes contains provisions that health disparities researchers say could disquali
statnews.com·14h ago
40-year research veteran warns new federal grantmaking rule threatens American scientific enterprise
David J. Skorton, president of the Association of American Medical Colleges and a 40-year research veteran, argues that a new federal grantm
statnews.com·1d ago40-year research veteran warns new federal grantmaking rule threatens American scientific enterprise
David J. Skorton, president of the Association of American Medical Colleges and a 40-year research veteran, argues that a new federal grantm
statnews.com·1d ago
Pharma CEOs' silence enables Trump administration's assault on U.S. biomedical research, argues Washington editor
The article argues that pharma CEOs are complicit in the destruction of U.S. science by remaining silent as the Trump administration, partic
biocentury.com·20d ago
NIH genomic data security rules slow research progress, spark workarounds among scientists
The National Institutes of Health (NIH) implemented new security rules (NIST SP 800-171) for genomic data sets in spring 2025, requiring res
science.org·9h ago
Experts and former FDA staff call for reforms to FDA's National Priority Voucher program at public hearing
Experts and former FDA staffers testified at a public hearing calling for significant reforms to the FDA's Commissioner's National Priority
cen.acs.org·16d agoComments
Sign in to join the conversation.
No comments yet. Be the first.